Literature DB >> 26178367

Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis).

Immacolata Andolfo1,2, Roberta Russo1,2, Francesco Manna1,2, Boris E Shmukler3,4, Antonella Gambale1,2, Giuseppina Vitiello2,5, Gianluca De Rosa1,2, Carlo Brugnara6, Seth L Alper3, L Michael Snyder7,8, Achille Iolascon1,2.   

Abstract

Dehydrated hereditary stomatocytosis (DHSt) is an autosomal dominant congenital hemolytic anemia with moderate splenomegaly and often compensated hemolysis. Affected red cells are characterized by a nonspecific cation leak of the red cell membrane, reflected in elevated sodium content, decreased potassium content, elevated MCHC and MCV, and decreased osmotic fragility. The majority of symptomatic DHSt cases reported to date have been associated with gain-of-function mutations in the mechanosensitive cation channel gene, PIEZO1. A recent study has identified two families with DHSt associated with a single mutation in the KCNN4 gene encoding the Gardos channel (KCa3.1), the erythroid Ca(2+) -sensitive K(+) channel of intermediate conductance, also expressed in many other cell types. We present here, in the second report of DHSt associated with KCNN4 mutations, two previously undiagnosed DHSt families. Family NA exhibited the same de novo missense mutation as that recently described, suggesting a hot spot codon for DHSt mutations. Family WO carried a novel, inherited missense mutation in the ion transport domain of the channel. The patients' mild hemolytic anemia did not improve post-splenectomy, but splenectomy led to no serious thromboembolic events. We further characterized the expression of KCNN4 in the mutated patients and during erythroid differentiation of CD34+ cells and K562 cells. We also analyzed KCNN4 expression during mouse embryonic development.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26178367     DOI: 10.1002/ajh.24117

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  38 in total

1.  Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis.

Authors:  Edyta Glogowska; Eve R Schneider; Yelena Maksimova; Vincent P Schulz; Kimberly Lezon-Geyda; John Wu; Kottayam Radhakrishnan; Siobán B Keel; Donald Mahoney; Alison M Freidmann; Rachel A Altura; Elena O Gracheva; Sviatoslav N Bagriantsev; Theodosia A Kalfa; Patrick G Gallagher
Journal:  Blood       Date:  2017-07-17       Impact factor: 22.113

2.  Gardos channelopathy: functional analysis of a novel KCNN4 variant.

Authors:  Elisa Fermo; David Monedero-Alonso; Polina Petkova-Kirova; Asya Makhro; Laurent Pérès; Guillaume Bouyer; Anna Paola Marcello; Filomena Longo; Giovanna Graziadei; Wilma Barcellini; Anna Bogdanova; Stephane Egee; Lars Kaestner; Paola Bianchi
Journal:  Blood Adv       Date:  2020-12-22

3.  Red blood cell Gardos channel (KCNN4): the essential determinant of erythrocyte dehydration in hereditary xerocytosis.

Authors:  Raphaël Rapetti-Mauss; Véronique Picard; Corinne Guitton; Khaldoun Ghazal; Valérie Proulle; Catherine Badens; Olivier Soriani; Loïc Garçon; Hélène Guizouarn
Journal:  Haematologica       Date:  2017-06-15       Impact factor: 9.941

4.  Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.

Authors:  Christiane K Bauer; Pauline E Schneeberger; Fanny Kortüm; Janine Altmüller; Fernando Santos-Simarro; Laura Baker; Jennifer Keller-Ramey; Susan M White; Philippe M Campeau; Karen W Gripp; Kerstin Kutsche
Journal:  Am J Hum Genet       Date:  2019-05-30       Impact factor: 11.025

Review 5.  The mechanosensitive Piezo1 channel: structural features and molecular bases underlying its ion permeation and mechanotransduction.

Authors:  Yubo Wang; Bailong Xiao
Journal:  J Physiol       Date:  2017-12-19       Impact factor: 5.182

6.  Senicapoc: a potent candidate for the treatment of a subset of hereditary xerocytosis caused by mutations in the Gardos channel.

Authors:  Raphael Rapetti-Mauss; Olivier Soriani; Henri Vinti; Catherine Badens; Hélène Guizouarn
Journal:  Haematologica       Date:  2016-07-21       Impact factor: 9.941

7.  Next generation research and therapy in red blood cell diseases.

Authors:  Roberta Russo; Immacolata Andolfo; Achille Iolascon
Journal:  Haematologica       Date:  2016-05       Impact factor: 9.941

8.  Red cell membrane disorders: structure meets function.

Authors:  Mary Risinger; Theodosia A Kalfa
Journal:  Blood       Date:  2020-09-10       Impact factor: 22.113

9.  Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures.

Authors:  Chia-Hsueh Lee; Roderick MacKinnon
Journal:  Science       Date:  2018-05-04       Impact factor: 47.728

Review 10.  New insights on hereditary erythrocyte membrane defects.

Authors:  Immacolata Andolfo; Roberta Russo; Antonella Gambale; Achille Iolascon
Journal:  Haematologica       Date:  2016-10-18       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.